Sprout Health review
Flat pricing across dose escalations is a genuine virtue, and it sits under a landing page advertising a first-month rate as if it were the price, two brand-name drugs you cannot buy, and no mention of pregnancy anywhere. The FDA letter is about exactly that habit.
then $299/mo ongoing
- FSA / HSA-eligible
- Independently scored
- Verified
Referral link, walled off from the rating
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Sprout Health at a glance
- Semaglutide
- $299/mo
- Tirzepatide
- $349/mo
- Coverage
- 44 states (not AL, AR, CA, LA, MS, ND)
- Brand-name
- Compounded only
How we scored Sprout Health
Each factor is scored from Sprout Health's real pricing, disclosures and oversight, then combined into the 54/100 Editors' Rating by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable, premium, or hides behind a plan commitment.
Limited public detail on who oversees care and how.
The headline rate obscures a plan requirement or a hidden step-up.
No postpartum, breastfeeding, or hormonal framing — a generic program.
Support is thin once the prescription ships.
Complaints cluster around billing lock-in and hard cancellation.
How we verified this review
- Last verified
- July 2026
- Confidence
- medium
- Primary source
- joinsprouthealth.com/start-weightloss
Operated by Sprout Health Partners LLC (Encinitas, CA); prescribing runs through MD Integrations, and two pharmacy partners are named — Foothills Pharmacy and Promise Pharmacy — though no individual clinician is named anywhere on the site. Ongoing prices ($299 semaglutide, $349 tirzepatide) and the multi-month tiers were verified two independent ways — the live checkout and the site's own embedded price table — which agree exactly. Flat-across-dose is stated explicitly: the price at subscription is honoured 'even if your dosage increases and more vials are needed'. $99/$149 is a first-month rate under an advertised welcome code; a separate FIRST150 code yields $149/$199, and the storefront ALSO advertises 'starting at $149' and 'starting at $199', so at least three price sets circulate publicly at once. STATE COUNT CONTRADICTS ITSELF: the terms list 44 served states and exclude AL, AR, CA, LA, MS and ND, while the privacy policy on the same domain says services are available in all 50 and lists the six excluded ones among them. We publish the terms' figure as the more specific and more restrictive of the two and record the conflict; Arkansas appears on both the excluded list and the synchronous-video-required list in the same section. brandAccess is deliberately FALSE despite Wegovy and Zepbound being advertised: every product card resolves to the identical compounded intake URL, and the two properties disagree on the brand prices themselves ($1,799/$1,999 on the main site, $1,579/$1,249 on the affiliate lander). PAYMENT IS TAKEN BEFORE THE MEDICAL QUESTIONNAIRE — the site's own how-it-works page puts purchase at step two and the detailed health history after it. Refunds after clinician review carry a $50 clinical review fee that the marketing pages omit; cancellation needs 48 hours' notice, pauses 5 business days. Carries an FDA warning letter (MARCS-CMS 715879, 09/09/2025, signed by the CDER Director) over the claim that GLP-1 medications are FDA-approved, with no close-out letter found; the specific sentence appears remediated, but a live page still claims 'up to a maximum of 30%' weight loss, which the tirzepatide trial literature does not support. BBB rates it F — 64 complaints with 32 unanswered, and a 1-out-of-5 customer review average across 16 reviews dominated by charged-but-never-shipped and cannot-cancel accounts. NOT VERIFIED: Trustpilot blocks automated reads and third-party figures conflict, so no rating is published here; the LegitScript badge could not be confirmed; the post-payment questionnaire is gated, so whether pregnancy is screened privately is unknown. ZERO mentions of pregnancy, breastfeeding, contraception, labs, PCOS or a BMI threshold appear on any public page. Flagged featured_blocked in provider-economics.json on the same basis as Direct Meds.
What to expect when you sign up
We walked Sprout Health's public signup funnel (July 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Prices are public and readable with no gate — the quiz stands before purchase, not before the number
- 2Every call to action, including the ones beside the brand-name listings, routes to the same compounded-only intake
- 3A short pre-qualification quiz comes next, and then payment is taken
- 4Only after payment does the detailed medical questionnaire appear, which a clinician reviews before anything ships
What we noticed
- Payment is collected BEFORE the medical questionnaire — the site's own how-it-works page puts purchasing at step two and the detailed health history after it
- Pricing is flat across dose escalations, stated plainly: the price at subscription is honoured even if the dose rises and more vials are needed
- Wegovy and Zepbound are listed with prices but every product card resolves to the identical compounded intake URL
- The clinical network is MD Integrations, and two pharmacy partners are named — Foothills Pharmacy and Promise Pharmacy — but no individual clinician is named anywhere on the site
- Nothing on any public page mentions pregnancy, breastfeeding, contraception, labs or a BMI threshold
Pricing
Prices re-verified
| Medication | Plan | Monthly |
|---|---|---|
| Compounded semaglutide | Monthly plan$99 applies to the first month only, on the monthly plan, under an advertised welcome code. The standing rate is $299. | $99 → $299 |
| Compounded tirzepatide | Monthly plan$149 first month only under the same welcome code; $349 thereafter. | $149 → $349 |
| Compounded semaglutide | 3-month prepayPer-month rate when three months are paid up front. | $205 |
| Compounded tirzepatide | 3-month prepayPer-month rate when three months are paid up front. | $250 |
| Compounded semaglutide | 6-month prepayPer-month rate when six months are paid up front — the cheapest route, and the least reversible. | $169 |
| Compounded tirzepatide | 6-month prepayPer-month rate when six months are paid up front. | $229 |
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect Sprout Health's public disclosures at last review and change often; confirm the current number on Sprout Health's own site.
What we like
- Pricing is genuinely flat across dose escalations — the rate at signup is honoured even when the dose rises and more vials are needed
- Both molecules are offered, with three- and six-month tiers that bring the per-month rate down substantially
- Names its clinical network (MD Integrations) and two pharmacy partners, Foothills and Promise — disclosure many competitors withhold
- State coverage is published as an actual list rather than a vague nationwide claim
The caveats
- No mention of pregnancy, breastfeeding or contraception on any public page — the only published contraindication is thyroid cancer and MEN 2
- Payment is collected before the detailed medical questionnaire, so money changes hands before any health history is taken
- Carries an FDA warning letter (MARCS-CMS 715879, 09/09/2025) over the claim that GLP-1 medications are FDA-approved, with no close-out published
- Rated F by the Better Business Bureau — 64 complaints, 32 unanswered, and a one-star average dominated by charged-but-never-shipped and cannot-cancel accounts
- Advertises Wegovy and Zepbound at four-figure prices that cannot be bought — every brand card resolves to the same compounded-only intake
- At least three price sets circulate at once, and refunds after clinician review carry a $50 fee the marketing pages never mention
- No named clinician anywhere on the site, and no labs are offered or required
Sprout Health for mothers: our verdict
Flat pricing across dose escalations is a genuine virtue, and it sits under a landing page advertising a first-month rate as if it were the price, two brand-name drugs you cannot buy, and no mention of pregnancy anywhere. The FDA letter is about exactly that habit. The advertised entry is $99, but the standing rate settles near $299/month — so read the headline as a starting offer, not the real monthly cost.
We weigh Sprout Health the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the parts a generic weight-loss review skips.
What Sprout Health actually costs
- Compounded semaglutide — Monthly plan: $99 to start, then $299/mo
- Compounded tirzepatide — Monthly plan: $149 to start, then $349/mo
- Compounded semaglutide — 3-month prepay: $205/mo
- Compounded tirzepatide — 3-month prepay: $250/mo
- Compounded semaglutide — 6-month prepay: $169/mo
- Compounded tirzepatide — 6-month prepay: $229/mo
For context, the typical ongoing price across our roster is around $187/month, so Sprout Health sits at the premium end.
The medications Sprout Health prescribes
Sprout Health prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Sprout Health fits — and where it doesn't — for mothers
A good fit if…
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- a clean regulatory record is a dealbreaker — note the FDA warning flagged in the cons above.
- you want frictionless cancellation — the fine print here is where the complaints cluster.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. It carries an FDA warning letter, flagged in the cons — read it before starting. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Sprout Health is a provider we list only with full disclosure — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Hard to recommend ahead of cleaner partners on this masthead. If the flat-across-doses structure is what you need, price the full year rather than the headline, and raise pregnancy and contraception yourself, because the site never will.
Alternatives to Sprout Health
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Enhance MD
One of the better-disclosed cash compounders we've reviewed for mothers — a named medical director, named pharmacies and real Quest lab work behind a flat, all-dose price. You trade a little more signup friction for oversight that actually behaves like oversight.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
Keep comparing Sprout Health
Head-to-head & alternatives
Sprout Health, answered
- Why does Sprout Health advertise $99 when the price is $299?
- Because $99 is a first-month welcome-code rate on the monthly plan, and $299 is what you pay every month after that — a gap of about $200 on semaglutide, and $149 against $349 on tirzepatide. Its storefront separately advertises 'starting at $149,' which matches neither figure. The one honest way to price this program is by what a full year costs, not by the number on the landing page, and the only route to a competitive per-month rate is prepaying six months up front.
- Can I actually get Wegovy or Zepbound from Sprout Health?
- No. Sprout Health lists Wegovy at $1,799 and Zepbound at $1,999, but there is no brand product in its checkout catalogue and every call-to-action beside those listings routes to the same compounded-only flow. We record its brand-name access as unavailable for that reason. If an FDA-approved brand pen with the manufacturer's own pregnancy and lactation labeling is what you want to hand your OB, this is not the program that provides it, whatever the price list implies.
- Does Sprout Health carry any regulatory history?
- Yes, and we list it plainly. The FDA issued a warning letter on 09/09/2025 (MARCS-CMS 715879), signed by the director of its drug centre, over the claim that GLP-1 medications are FDA-approved — compounded drugs are not, and the agency called the claim false or misleading. That is a labeling and advertising problem rather than a product-safety finding, and the specific sentence appears to have been removed since. No close-out letter has been published. Separately, the Better Business Bureau rates the company F, with 64 complaints of which 32 went unanswered, and a one-star customer average. None of that changes the medication; it tells you what recourse looks like if something goes wrong.
- Will Sprout Health serve my state?
- Its terms say 44 states, excluding Alabama, Arkansas, California, Louisiana, Mississippi and North Dakota, with no District of Columbia coverage. Its privacy policy, on the same domain, says all 50 and lists those six among them. Both cannot be true. We publish the more restrictive figure because it is the more specific document, but the honest answer is that Sprout does not currently give a reliable account of where it operates — so confirm your own state before you prepay for six months of anything.
- Does Sprout Health say anything about pregnancy or breastfeeding?
- No — and on this masthead that is the finding that matters most. Across every public page, including the terms, the refund policy and each drug page, there is no mention of pregnancy, breastfeeding or contraception anywhere. The only contraindication published is thyroid cancer and MEN 2. Payment is also taken before the detailed medical questionnaire, and that questionnaire isn't publicly readable, so we cannot say whether it screens privately. What we can say is that a prospective patient is asked for money before she is asked anything about pregnancy. Given that GLP-1s are contraindicated in pregnancy and that tirzepatide is labeled as reducing oral contraceptive absorption, that ordering is the wrong way round.
Pricing, states and verification reflect Sprout Health's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.